幽门螺杆菌致病机制与防治研究进展

被引：31

作者：

王猛

穆红

机构：

[1] 天津市第一中心医院检验科

来源：

中华临床实验室管理电子杂志 | 2017年 / 5卷 / 03期

关键词：

幽门螺杆菌; 胃癌; 流行病学; 治疗与预防;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

胃癌的发生是多阶段、多因素共同作用的结果,而幽门螺杆菌(Helicobacter pylori,Hp)感染是胃癌发生、发展的重要启动因素。对Hp感染的发病机制、流行病学以及治疗预防这几方面的研究能够有效的提高Hp的清除率。对于Hp感染的预防以及治疗能从多角度降低消化道溃疡或者胃癌的发病率与病死率。

引用

页码：135 / 140

页数：6

共 26 条

[1]

气温、气压、湿度的变化对消化性溃疡发病影响的研究 [J].

刘达云 ;

高安宁 ;

唐国都 ;

黄钢丁 ;

孙丽玲 ;

覃江 ;

谢月萍 ;

杨望月 ;

梁仲惠 ;

苏东星 .

临床消化病杂志, 2009, 21 (01) :3-7

[2]

Expression of Helicobacter pylori AlpA protein and its immunogenicity [J].

Xue, Jing ;

Bai, Yang ;

Chen, Ye ;

Wang, Ji-De ;

Zhang, Zhao-Shan ;

Zhang, Ya-Li ;

Zhou, Dian-Yuan .

WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (15) :2260-2263

[3]

Cloning and expression and immunogenicity of Helicobacter pylori BabA2 gene [J].

Bai, Yang ;

Zhang, Ya-Li ;

Chen, Ye ;

Jin, Jian-Feng ;

Zhang, Zhao-Shan ;

Zhou, Dian-Yuan .

WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (17) :2560-2562

[4]

Circulating blood levels of IL-6; IFN-γ; and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.[J].Norma Sánchez-Zauco;Javier Torres;Alejandro Gómez;Margarita Camorlinga-Ponce;Leopoldo Mu?oz-Pérez;Roberto Herrera-Goepfert;Rafael Medrano-Guzmán;Silvia Giono-Cerezo;Carmen Maldonado-Bernal.BMC Cancer.2017, 1

[5]

Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children [J].

Butenko, Tita ;

Jeverica, Samo ;

Orel, Rok ;

Homan, Matjaz .

HELICOBACTER, 2017, 22 (05)

[6]

The study of H-pylori putative candidate factors for single- and multi-component vaccine development [J].

Mirzaei, Nasrin ;

Poursina, Farkhondeh ;

Moghim, Sharareh ;

Rashidi, Niloufar ;

Safaei, Hajieh Ghasemian .

CRITICAL REVIEWS IN MICROBIOLOGY, 2017, 43 (05) :631-650

[7]

Helicobacter pylori, Its Urease and Carbonic Anhydrases, and Macrophage Nitric Oxide Synthase [J].

Tsikas, Dimitrios ;

Hanff, Erik ;

Brunner, Gorig .

TRENDS IN MICROBIOLOGY, 2017, 25 (08) :601-602

[8]

Validation of a Novel Immunoline Assay for Patient Stratification according to Virulence of the Infecting Helicobacter pylori Strain and Eradication Status.[J].Luca Formichella;Laura Romberg;Hannelore Meyer;Christian Bolz;Michael Vieth;Michael Geppert;Gereon G?ttner;Christina N?lting;Wolfgang Schepp;Arne Schneider;Kurt Ulm;Petra Wolf;Ingrid Lisanne Holster;Ernst J. Kuipers;Bernd Birkner;Erwin Soutschek;Markus Gerhard;Kristen M. Kahle.Journal of Immunology Research.2017,

[9]

Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapy [J].

Zhu, Xin Yan ;

Liu, Fei .

JOURNAL OF DIGESTIVE DISEASES, 2017, 18 (04) :195-202

[10]

Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection A 1-week, open-label, randomized trial [J].

Su, Jing ;

Zhou, Xiaoying ;

Chen, Han ;

Hao, Bo ;

Zhang, Weifeng ;

Zhang, Guoxin .

MEDICINE, 2017, 96 (07)

← 1 2 3 →